Keyphrases
Finland
100%
Antiseizure Medication
50%
COVID-19 Pandemic
47%
Traumatic Brain Injury
46%
Myopathy
41%
University Hospital
39%
Confidence Interval
37%
Drug-resistant Epilepsy
35%
Seizure
34%
Epilepsy
29%
Computed Tomography
28%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
27%
Ischemic Stroke in Young Adults
27%
Cryptogenic Stroke
27%
Chronic Subdural Hematoma
27%
Epileptic Seizure
26%
Glial Fibrillary Acidic Protein
26%
Motor Seizures
25%
Epilepsy Patients
25%
Older Adults
23%
Tampere
23%
Biallelic
22%
Vagus Nerve Stimulation
22%
Executive Function
21%
Health Decision-making
21%
Healthcare Professionals
21%
Shared Decision Making
20%
Interleukin-6
20%
Titin
20%
Anterior Thalamus
19%
Deep Brain Stimulation
19%
Neurologist
19%
Systematic Literature Review
19%
Oxcarbazepine
19%
Spinal Cord Injury
19%
Neurological Outcome
19%
Population-based Study
19%
Age of Onset
19%
Seizure Freedom
19%
Medication Dosing
18%
Tonic
18%
Celiac Disease
18%
Consensus Recommendations
18%
Brain Arteriovenous Malformation (bAVM)
18%
Hippocampal Sclerosis
18%
Titinopathy
18%
Head Injury
18%
Incidence Rate
18%
Drug-resistant Temporal Lobe Epilepsy
18%
Medtronic
18%
Randomized Clinical Trial
18%
Digital Services
18%
Video Recording
18%
Traumatic Spinal Cord Injury
18%
Ischemic Stroke
18%
Quality of Life
17%
Poor Outcome
17%
Comprehensive Stroke Center
16%
Pathophysiology
16%
Seizure-free
16%
Patients with Epilepsy
15%
Clinical Features
15%
Scandinavian
15%
ANT-DBS
15%
Surgically Treated
14%
Functional Outcome
14%
Emergency Department Visits
14%
Motion Signal
14%
Seizure Frequency
14%
Clinical Practice
13%
Hazard Ratio
13%
Natalizumab
13%
Truncating Variant
13%
Homozygosity
13%
Finnish Population
13%
Cause of Death
13%
Risk Factors
13%
Multiple Sclerosis
13%
Modified Rankin Scale
13%
Adult Patients
13%
Seizure Type
13%
New-onset Epilepsy
13%
Brain Injury
13%
Parkinson's Disease
13%
All-cause Mortality
13%
Signaling Profile
13%
Healthcare
13%
Myalgia
12%
Seizure Detection
12%
Subgroup Analysis
12%
Mild Traumatic Brain Injury (mTBI)
12%
Register Study
12%
Muscle Disease
12%
Emergency Surgery
12%
Myoclonic Epilepsy
11%
Acute Ischemic Stroke
11%
Acute Management
11%
Video Monitoring
11%
Defined Daily Dose
11%
Mouse Model
11%
Medicine and Dentistry
Epileptic Seizure
56%
Brain Ischemia
39%
Drug Resistant Epilepsy
29%
Subdural Hematoma
28%
Deep Brain Stimulation
27%
Computer Assisted Tomography
25%
Aneurysm
25%
Diseases
23%
Systematic Review
23%
Apoplexy
22%
Stimulation Therapy
20%
Thalamus
20%
Executive Function
19%
Traumatic Brain Injury
19%
Interleukin 6
18%
Vagus Nerve Stimulation
18%
Biological Marker
18%
Randomized Clinical Trial
18%
Traumatic Spinal Cord Injury
18%
Comorbidity
17%
Modified Rankin Scale
16%
Magnetic Resonance Imaging
16%
Mortality Rate
16%
Adverse Event
15%
Cognitive Defect
14%
Triage
14%
Intracranial Aneurysm
13%
Pathophysiology
13%
Cohort Analysis
12%
Side Effect
12%
Ganglioglioma
12%
Neurology
12%
Stereotypic Movement Disorder
11%
Health Care
11%
Decision Making
11%
Glioblastoma
11%
Headache
11%
COVID-19
10%
Myopathy
10%
Neoplasm
10%
Spinal Cord Injury
10%
Subarachnoid Hemorrhage
10%
Retrospective Study
9%
Patient Registry
9%
Rehabilitation Engineering
9%
Neuropathic Pain
9%
Streptococcus intermedius
9%
Brain Ventriculitis
9%
Leg Pain
9%
Viridans streptococci
9%
Surgical Emergency
9%
Coeliac Disease
9%
Exercise Test
9%
Oligoastrocytoma
9%
Cerebral Arteriovenous Malformation
9%
e-Health
9%
Periodontitis
9%
Closed Head Injury
9%
Maturity Onset Diabetes of the Young
9%
Cervical Spinal Cord Injury
9%
Glial Fibrillary Acidic Protein
9%
Observational Study
9%
Muscle Disease
9%
Vascular Disease
9%
Hippocampal Sclerosis
9%
Glutamate Decarboxylase
9%
Anoctamin
9%
Trail Making Test
9%
Thrombectomy
9%
Patient Referral
9%
Status Epilepticus
9%
Mean Arterial Pressure
9%
Hormone Determination
9%
Dysplasia
9%
Dermatitis Herpetiformis
9%
Neurosurgery
9%
Temporal Lobe Epilepsy
9%
Polytrauma
9%
Blood Pressure
9%
Macrophage
9%
Multiple Sclerosis
9%
Radiographer
9%
Thrombus
9%
Adjuvant Therapy
9%
Cesarean Section
9%
Neuropsychological Testing
9%
Reoperation
9%
Noninferiority Trial
9%
Atherosclerosis
9%
Transient Ischemic Attack
9%
Tractography
9%
Medical Device
9%
Diffusion MRI
9%
Alcohol Consumption
9%
Fecal Microbiota Transplantation
9%
Retrospective Cohort Study
9%
Pandemic
9%
Case-Control Study
9%
Shared Decision Making
9%
Health Service
9%